We believe that when medically indicated, cannabis/marijuana should be: accessible, safe, affordable, reliable, and equally recognized as a prescription medication.
Three key points for medical cannabis patients: Simple and safe access to quality product; affordability, enabling drug insurance and eliminating sales taxes; more research to define doses and understand best uses TORONTO, Ontario – August 29, 2016 – Three leading Canadian patient advocacy groups, along with 14 signatories, today presented to the federal government’s Task Force on the Legalization and Regulation of Marijuana a brief highlighting the currently unmet needs of medical cannabis patients and how those needs should be … read more
WATERLOO, ON, Aug. 11, 2016 /CNW/ – Today, Health Canada introduced revised medical cannabis regulations related to the Allard case, the Federal Court case that struck down the unconstitutional Marihuana for Medical Purposes Regulations (MMPR) due to concerns around inadequate access and home growing. The revised Access to Cannabis for Medical Purposes Regulations announced today are similar to the previous cannabis regulatory regime, where under the MMAR patients were able to grow at home or designate another grower to produce … read more
Recommendations provide guidance around affordability, research and other issues to ensure fair access to medical cannabis OTTAWA – May 9 2016 – Canadians for Fair Access to Medical Marijuana (CFAMM), a federal non-profit, medical cannabis patient rights organization, today issued a set of recommendations to guide federal decision-makers on the needs of medical cannabis patients. CFAMM is joined by The Arthritis Society in urging federal policymakers to take action in five key areas: (1) eliminate sales tax; (2) facilitate insurance … read more